| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in Regulating the Expression of Death-Associated Protein Kinase-1
Department of Microbiology & Immunology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201
* To whom correspondence should be addressed. Email: dkalvako{at}umaryland.edu.
| Abstract |
|---|
Transcription factor C/EBP-
regulates a number of physiologic responses. During an investigation of the growth-suppressive effects of IFNs, we noticed that cebpb -/- cells fail to undergo apoptosis upon IFN-
treatment compared to the wild-type controls. To examine the basis for this response, we have performed a gene expression profiling of the isogenic wild-type and cebpb -/- bone marrow macrophages and identified a number of IFN-
regulated genes that are dependent on C/EBP-
for their expression. These genes are distinct from those regulated by the JAK-STAT pathways. Genes identified in this screen appear to participate in various cellular pathways. Thus, we identify a new pathway through which the IFNs exert their effects on cellular genes through C/EBP-
. One of these genes is the death-associated protein kinase 1 (dapk1). DAPK1 is critical for regulating cell cycle, apoptosis and metastasis. Using site-directed mutagenesis, RNAi and ChIP assays, we show that C/EBP-
binds to the promoter of dapk1 and is required for the regulation of dapk1. Both mouse and human dapk1 exhibited similar dependence on C/EBP-
for their expression. The expression of the other members of DAPK family occurred independently of C/EBP-
. Members of the C/EBP family of transcription factors, other than C/EBP-
did not significantly affect dapk1 expression. We identified two elements in this promoter that respond to C/EBP-
. One of these is a consensus CBS that constitutively binds to C/EBP-
. The other element exhibits homology to the cAMP-response element/activating transcription factor binding sites. C/EBP-
binds to this site in an IFN-
-dependent manner. Inhibition of ERK1/2 or mutation of an ERK1/2 site in the C/EBP-
protein suppressed the IFN-
-induced response of this promoter. Together our data show a critical role for C/EBP-
in a novel IFN-induced cell growth-suppressive pathway via DAPK1.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|